FRM
VOR icon

Fox Run Management’s Vor Biopharma VOR Stock Holding History

Fox Run Management’s Portfolio VOR Stock Details VOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$282K Buy
+15,301
New +$232K 0.05% 699

Other funds holding VOR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NFT
Nan Fung Trinity Central, Hong Kong, Hong Kong $1.01B AUM 64.38% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
AA
ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $799M AUM 253.51% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

Fox Run Management's VOR Position: Q2 2026 in Review

Fox Run Management opened a new position in Vor Biopharma (VOR) in Q2 2026: 15,301 shares worth $282K. The stake represents 0.05% of the portfolio and ranks #699 among its holdings.

25 funds tracked by Wall St. Rank hold VOR as of Q2 2026.

  • Fox Run Management held 15,301 shares of Vor Biopharma worth $282K as of Q2 2026.
  • Vor Biopharma was a new Fox Run Management position in Q2 2026.
  • Vor Biopharma made up 0.05% of Fox Run Management's portfolio in Q2 2026, its #699 holding.
  • 25 funds tracked by Wall St. Rank held Vor Biopharma as of Q2 2026.

Based on Fox Run Management's 13F filing for Q2 2026, filed 4 Aug 2026.